EIQ
ECHOIQLTD FPO [EIQ]
Healthcare · ASX Small Cap
$0.6300 +1.6%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical48
Catalyst51
Sentiment50
Fundamental54
Momentum60
Risk Gate35
Active Signals
Bullish Signals
- Price above MAs (uptrend)
- OBV divergence: distribution detected
- Testing resistance level
- Above 200-day MA (long-term uptrend)
- Adequate cash runway (5 quarters)
- Very high P/S ratio (1860.8x)
- EPS estimates revised upward (+10pts)
- Near 52-week high (96% of range)
- Capital raise activity (1 events)
- CANSLIM N: Near 52-week high (breakout territory)
- Positive 12-1 momentum (+43%)
- Altman Z-Score in distress zone (1.77 < 1.81)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- RSI overbought (caution)
- Stochastic overbought
- Revenue declining (-12%)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-12%)
Recent Catalysts
NONE Half Year Accounts 31 December 2025
NONE Appendix 4D 31 December 2025
NONE Change of Director's Interest Notice x2
Recent ASX Announcements
| 2026-02-26 | Half Year Accounts 31 December 2025 |
| 2026-02-26 | Appendix 4D 31 December 2025 PRICE SENSITIVE |
| 2026-02-20 | Change of Director's Interest Notice x2 |
| 2026-02-20 | Cleansing Notice |
| 2026-02-20 | Application for quotation of securities - EIQ |
Key Metrics
$406.4M
Market Cap
2.3M
Avg Volume
0.9x
Vol Ratio
$0.17 — $0.64
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
-115.2%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | pass | Near 52w High |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | pass | RS: 34 |
| I | Institutional Sponsorship | weak | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #43 of 119 · Sector avg: 51
View all Healthcare signals →